Vaxcyte, Inc.
NASDAQ:PCVX
99.38 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 397.451 | 834.657 | 68.985 | 386.2 | 58.976 | 66.09 | 36.139 |
| Short Term Investments
| 682.776 | 96.719 | 176.985 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,080.227 | 931.376 | 245.97 | 386.2 | 58.976 | 66.09 | 36.139 |
| Net Receivables
| 3.607 | 1 | 1.2 | 0.3 | 0.2 | 0 | 0 |
| Inventory
| -6.159 | -1 | -1.2 | -0.3 | -0.2 | 0 | 0 |
| Other Current Assets
| 18.279 | 11.179 | 10.378 | 2.804 | 2.747 | 0.578 | 0.209 |
| Total Current Assets
| 1,095.954 | 942.555 | 256.348 | 389.004 | 61.723 | 66.668 | 36.348 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 110.623 | 31.648 | 35.912 | 3.272 | 3.391 | 3.411 | 2.972 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 163.778 | 26.549 | 27.117 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 37.562 | 5.426 | 4.96 | 0.55 | 0.584 | 0.723 | 0.311 |
| Total Non-Current Assets
| 311.963 | 63.623 | 67.989 | 3.822 | 3.975 | 4.134 | 3.283 |
| Total Assets
| 1,407.917 | 1,006.178 | 324.337 | 392.826 | 65.698 | 70.802 | 39.631 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 14.587 | 9.795 | 6.758 | 29.785 | 3.376 | 2.83 | 1.808 |
| Short Term Debt
| 14.226 | 5.91 | 5.276 | 0 | 0.161 | 0.297 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -119.695 | 0 | 0 | 0 | 0 | -0.297 | 0 |
| Other Current Liabilities
| 355.915 | 15.025 | 9.924 | -12.709 | 4.139 | 1.053 | 0.647 |
| Total Current Liabilities
| 145.338 | 40.525 | 28.716 | 46.861 | 11.052 | 6.713 | 4.263 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 44.222 | 12.031 | 11.507 | 0 | 0 | 0.161 | 4.218 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -22.111 | 0.009 | 0.096 | 0.122 | 161.019 | 121.656 | 0.212 |
| Total Non-Current Liabilities
| 22.111 | 12.04 | 11.603 | 0.122 | 161.019 | 121.817 | 4.43 |
| Total Liabilities
| 167.449 | 52.565 | 40.319 | 46.983 | 172.071 | 128.53 | 8.693 |
| Equity: | |||||||
| Preferred Stock
| 2,164.583 | 0 | 324.337 | 392.826 | 160.31 | 117.81 | 60.068 |
| Common Stock
| 0.098 | 0.082 | 0.056 | 0.054 | 0.007 | 0.006 | 0.006 |
| Retained Earnings
| -924.392 | -522.126 | -298.641 | -198.564 | -109.347 | -59.073 | -29.588 |
| Accumulated Other Comprehensive Income/Loss
| 0.179 | -0.361 | -0.241 | -392.826 | -160.31 | -1.751 | 0 |
| Other Total Stockholders Equity
| 2,164.583 | 1,476.018 | 258.507 | 544.353 | 2.967 | -114.72 | 0.452 |
| Total Shareholders Equity
| 1,240.468 | 953.613 | 284.018 | 345.843 | -106.373 | -57.728 | 30.938 |
| Total Equity
| 1,240.468 | 953.613 | 284.018 | 345.843 | -106.373 | -57.728 | 30.938 |
| Total Liabilities & Shareholders Equity
| 1,407.917 | 1,006.178 | 324.337 | 392.826 | 65.698 | 70.802 | 39.631 |